Virus filtration of high-concentration monoclonal antibody solutions
- PMID: 19353736
- DOI: 10.1002/btpr.177
Virus filtration of high-concentration monoclonal antibody solutions
Abstract
The ability to process high-concentration monoclonal antibody solutions (> 10 g/L) through small-pore membranes typically used for virus removal can improve current antibody purification processes by eliminating the need for feed stream dilution, and by reducing filter area, cycle-time, and costs. In this work, we present the screening of virus filters of varying configurations and materials of construction using MAb solutions with a concentration range of 4-20 g/L. For our MAbs of interest-two different humanized IgG1s-flux decay was not observed up to a filter loading of 200 L/m(2) with a regenerated cellulose hollow fiber virus removal filter. In contrast, PVDF and PES flat sheet disc membranes were plugged by solutions of these same MAbs with concentrations >4 g/L well before 50 L/m(2). These results were obtained with purified feed streams containing <2% aggregates, as measured by size exclusion chromatography, where the majority of the aggregate likely was composed of dimers. Differences in filtration flux performance between the two MAbs under similar operating conditions indicate the sensitivity of the system to small differences in protein structure, presumably due to the impact of these differences on nonspecific interactions between the protein and the membrane; these differences cannot be anticipated based on protein pI alone. Virus clearance data with two model viruses (XMuLV and MMV) confirm the ability of hollow fiber membranes with 19 +/- 2 nm pore size to achieve at least 3-4 LRV, independent of MAb concentration, over the range examined.
(c) 2009 American Institute of Chemical Engineers Biotechnol.
Similar articles
-
Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.Biotechnol Prog. 2015 Jan-Feb;31(1):135-44. doi: 10.1002/btpr.2020. Epub 2014 Nov 29. Biotechnol Prog. 2015. PMID: 25395156
-
Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process.Vox Sang. 2006 Aug;91(2):119-25. doi: 10.1111/j.1423-0410.2006.00792.x. Vox Sang. 2006. PMID: 16907872
-
Prediction of viral filtration performance of monoclonal antibodies based on biophysical properties of feed.Biotechnol Prog. 2015 May-Jun;31(3):765-74. doi: 10.1002/btpr.2094. Epub 2015 May 19. Biotechnol Prog. 2015. PMID: 25919945
-
Evaluation of anti-viral filters.Dev Biol Stand. 1996;88:91-8. Dev Biol Stand. 1996. PMID: 9119168 Review.
-
Membrane filtration for virus removal.Dev Biol (Basel). 2000;102:157-63. Dev Biol (Basel). 2000. PMID: 10794103 Review.
Cited by
-
Development of small-scale models to understand the impact of continuous downstream bioprocessing on integrated virus filtration.Biotechnol Prog. 2020 May;36(3):e2962. doi: 10.1002/btpr.2962. Epub 2020 Feb 3. Biotechnol Prog. 2020. PMID: 31945257 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous